{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T21:11:21Z","timestamp":1788901881032,"version":"build-2803163510"},"reference-count":159,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["320030_219676\/1"],"award-info":[{"award-number":["320030_219676\/1"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Immunology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.smim.2026.102055","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T12:07:49Z","timestamp":1787659669000},"page":"102055","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["IL-1-mediated cancer-adapted hematopoiesis in aging and clonal hematopoiesis"],"prefix":"10.1016","volume":"83","author":[{"given":"Francisco","family":"Caiado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagihan G.","family":"Gonullu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4096-4448","authenticated-orcid":false,"given":"Markus G.","family":"Manz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.smim.2026.102055_bib1","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nature12984","article-title":"The bone marrow niche for haematopoietic stem cells","volume":"505","author":"Morrison","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.smim.2026.102055_bib2","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nri2726","article-title":"Awakening dormant haematopoietic stem cells","volume":"10","author":"Trumpp","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.smim.2026.102055_bib3","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201541","article-title":"Inflammation as a regulator of hematopoietic stem cell function in disease, aging, and clonal selection","volume":"218","author":"Caiado","year":"2021","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.smim.2026.102055_bib4","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.stem.2023.09.013","article-title":"Hematopoietic stem cells through the ages: A lifetime of adaptation to organismal demands","volume":"30","author":"Kasbekar","year":"2023","journal-title":"Cell. Stem Cell."},{"key":"10.1016\/j.smim.2026.102055_bib5","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.stem.2017.06.013","article-title":"Pathogen-Induced TLR4-TRIF innate immune signaling in hematopoietic stem cells promotes proliferation but reduces competitive fitness","volume":"21","author":"Takizawa","year":"2017","journal-title":"Cell. Stem Cell."},{"key":"10.1016\/j.smim.2026.102055_bib6","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1084\/jem.20101643","article-title":"Dynamic variation in cycling of hematopoietic stem cells in steady state and inflammation","volume":"208","author":"Takizawa","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.smim.2026.102055_bib7","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1161\/ATVBAHA.119.312129","article-title":"New insights into the differentiation of megakaryocytes from hematopoietic progenitors","volume":"39","author":"Noetzli","year":"2019","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.smim.2026.102055_bib8","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/s41577-024-00998-7","article-title":"Made to order: emergency myelopoiesis and demand-adapted innate immune cell production","volume":"24","author":"Swann","year":"2024","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.smim.2026.102055_bib9","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1126\/science.abi5200","article-title":"The spectrum of inflammatory responses","volume":"374","author":"Medzhitov","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.smim.2026.102055_bib10","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1182\/blood-2017-06-780882","article-title":"Inflammation: a key regulator of hematopoietic stem cell fate in health and disease","volume":"130","author":"Pietras","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.smim.2026.102055_bib11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","article-title":"Inflammation and cancer: triggers, mechanisms, and consequences","volume":"51","author":"Greten","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.smim.2026.102055_bib12","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/BS9.0000000000000001","article-title":"The disruption of hematopoiesis in tumor progression","volume":"1","author":"Wang","year":"2019","journal-title":"Blood Sci."},{"key":"10.1016\/j.smim.2026.102055_bib13","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.3389\/fimmu.2022.1041010","article-title":"Hematologic dysfunction in cancer: mechanisms, effects on antitumor immunity, and roles in disease progression","volume":"13","author":"Plackoska","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.smim.2026.102055_bib14","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1182\/blood.2023023105","article-title":"IL-1 in aging and pathologies of hematopoietic stem cells","volume":"144","author":"Caiado","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.smim.2026.102055_bib15","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/imr.12614","article-title":"IL-1 and IL-1 regulatory pathways in cancer progression and therapy","volume":"281","author":"Mantovani","year":"2018","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.smim.2026.102055_bib16","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/s41423-025-01358-8","article-title":"IL-1 family cytokines in inflammation and immunity","volume":"22","author":"Garlanda","year":"2025","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.smim.2026.102055_bib17","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.immuni.2019.03.012","article-title":"Interleukin-1 and related cytokines in the regulation of inflammation and immunity","volume":"50","author":"Mantovani","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.smim.2026.102055_bib18","article-title":"Interleukin-1 (IL-1) pathway","volume":"3","author":"Weber","year":"2010","journal-title":"Sci. Signal."},{"key":"10.1016\/j.smim.2026.102055_bib19","doi-asserted-by":"crossref","first-page":"6477","DOI":"10.4049\/jimmunol.0803961","article-title":"IL-1R type I-dependent hemopoietic stem cell proliferation is necessary for inflammatory granulopoiesis and reactive neutrophilia","volume":"182","author":"Ueda","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2026.102055_bib20","first-page":"422","article-title":"Modulation of murine hematopoiesis in vivo with recombinant murine interleukin-1","volume":"8","author":"Gallicchio","year":"1989","journal-title":"J. Biol. Response Mod."},{"key":"10.1016\/j.smim.2026.102055_bib21","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1073\/pnas.85.5.1620","article-title":"A low dose of recombinant interleukin 1 protects granulocytopenic mice from lethal gram-negative infection","volume":"85","author":"van der Meer","year":"1988","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.smim.2026.102055_bib22","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1006\/clin.1994.1196","article-title":"The effect of treatment with interleukin-1 and tumor necrosis factor on Pseudomonas aeruginosa lung infection in a granulocytopenic mouse model","volume":"73","author":"Amura","year":"1994","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.smim.2026.102055_bib23","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.124213","article-title":"Aged marrow macrophages expand platelet-biased hematopoietic stem cells via interleukin-1B","volume":"4","author":"Frisch","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.smim.2026.102055_bib24","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1182\/blood.2021011570","article-title":"IL-1 mediates microbiome-induced inflammaging of hematopoietic stem cells in mice","volume":"139","author":"Kovtonyuk","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.smim.2026.102055_bib25","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41556-022-01053-0","article-title":"Stromal niche inflammation mediated by IL-1 signalling is a targetable driver of haematopoietic ageing","volume":"25","author":"Mitchell","year":"2023","journal-title":"Nat. Cell. Biol."},{"key":"10.1016\/j.smim.2026.102055_bib26","first-page":"4082","article-title":"Prevention of acute chemotherapy-induced death in mice by recombinant human interleukin 1: protection from hematological and nonhematological toxicities","volume":"52","author":"Damia","year":"1992","journal-title":"Cancer Res."},{"key":"10.1016\/j.smim.2026.102055_bib27","first-page":"1565","article-title":"Protective effects of recombinant human interleukin-1 alpha in doxorubicin-treated normal and tumor-bearing mice","volume":"53","author":"Lynch","year":"1993","journal-title":"Cancer Res."},{"key":"10.1016\/j.smim.2026.102055_bib28","first-page":"6469","article-title":"Combined interleukin-1 beta\/interleukin-6 treatment in mice: synergistic myelostimulatory activity and myelorestorative effect after cyclophosphamide-induced myelosuppression","volume":"54","author":"Tritarelli","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/j.smim.2026.102055_bib29","doi-asserted-by":"crossref","first-page":"6062","DOI":"10.1038\/s41467-023-41691-y","article-title":"Perivascular niche cells sense thrombocytopenia and activate hematopoietic stem cells in an IL-1 dependent manner","volume":"14","author":"Luis","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.smim.2026.102055_bib30","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/ncb3346","article-title":"Chronic interleukin-1 exposure drives haematopoietic stem cells towards precocious myeloid differentiation at the expense of self-renewal","volume":"18","author":"Pietras","year":"2016","journal-title":"Nat. Cell. Biol."},{"key":"10.1016\/j.smim.2026.102055_bib31","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41467-022-35700-9","article-title":"Endogenous IL-1 receptor antagonist restricts healthy and malignant myeloproliferation","volume":"14","author":"Villatoro","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.smim.2026.102055_bib32","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jaci.2015.11.028","article-title":"Hyperinflammation in patients with chronic granulomatous disease leads to impairment of hematopoietic stem cell functions","volume":"138","author":"Weisser","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.smim.2026.102055_bib33","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3324\/haematol.2018.197210","article-title":"Pro-inflammatory cytokine blockade attenuates myeloid expansion in a murine model of rheumatoid arthritis","volume":"105","author":"Hernandez","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.smim.2026.102055_bib34","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/808524","article-title":"PU.1 and haematopoietic cell fate: dosage matters","volume":"2011","author":"Mak","year":"2011","journal-title":"Int. J. Cell. Biol."},{"key":"10.1016\/j.smim.2026.102055_bib35","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201169","article-title":"PU.1 enforces quiescence and limits hematopoietic stem cell expansion during inflammatory stress","volume":"218","author":"Chavez","year":"2021","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.smim.2026.102055_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1204160","article-title":"PU.1 is required to restrain myelopoiesis during chronic inflammatory stress","volume":"11","author":"Chavez","year":"2023","journal-title":"Front. Cell. Dev. Biol."},{"key":"10.1016\/j.smim.2026.102055_bib37","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s12185-015-1764-6","article-title":"C\/EBP\u03b1 in normal and malignant myelopoiesis","volume":"101","author":"Friedman","year":"2015","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.smim.2026.102055_bib38","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200560","article-title":"Chronic interleukin-1 exposure triggers selection for Cebpa-knockout multipotent hematopoietic progenitors","volume":"218","author":"Higa","year":"2021","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.smim.2026.102055_bib39","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.semcancer.2011.01.002","article-title":"The secreted factors responsible for pre-metastatic niche formation: old sayings and new thoughts","volume":"21","author":"Peinado","year":"2011","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.smim.2026.102055_bib40","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.cell.2008.04.045","article-title":"Systemic endocrine instigation of indolent tumor growth requires osteopontin","volume":"133","author":"McAllister","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.smim.2026.102055_bib41","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/s12276-024-01192-4","article-title":"Extramedullary hematopoiesis in cancer","volume":"56","author":"Barisas","year":"2024","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.smim.2026.102055_bib42","doi-asserted-by":"crossref","first-page":"dju124","DOI":"10.1093\/jnci\/dju124","article-title":"Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis","volume":"106","author":"Templeton","year":"2014","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.smim.2026.102055_bib43","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.1073\/pnas.1320753111","article-title":"Circulating hematopoietic stem and progenitor cells are myeloid-biased in cancer patients","volume":"111","author":"Wu","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.smim.2026.102055_bib44","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41571-023-00846-y","article-title":"Myeloid-derived suppressor cells in cancer and cancer therapy","volume":"21","author":"Lasser","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.smim.2026.102055_bib45","doi-asserted-by":"crossref","first-page":"E566","DOI":"10.1073\/pnas.1424927112","article-title":"Invasive breast cancer reprograms early myeloid differentiation in the bone marrow to generate immunosuppressive neutrophils","volume":"112","author":"Casbon","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.smim.2026.102055_bib46","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1158\/0008-5472.CAN-15-0204","article-title":"Activation of hematopoietic stem\/progenitor cells promotes immunosuppression within the pre-metastatic niche","volume":"76","author":"Giles","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.smim.2026.102055_bib47","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1073\/pnas.1113744109","article-title":"Origins of tumor-associated macrophages and neutrophils","volume":"109","author":"Cortez-Retamozo","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.smim.2026.102055_bib48","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1172\/JCI97973","article-title":"Spleen mediates a distinct hematopoietic progenitor response supporting tumor-promoting myelopoiesis","volume":"128","author":"Wu","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.smim.2026.102055_bib49","doi-asserted-by":"crossref","first-page":"5514","DOI":"10.1158\/0008-5472.CAN-08-4625","article-title":"The liver is a site for tumor-induced myeloid-derived suppressor cell accumulation and immunosuppression","volume":"69","author":"Ilkovitch","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.smim.2026.102055_bib50","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s12015-019-09890-7","article-title":"The Nlrp3 inflammasome orchestrates mobilization of bone marrow-residing stem cells into peripheral blood","volume":"15","author":"Lenkiewicz","year":"2019","journal-title":"Stem Cell. Rev. Rep."},{"key":"10.1016\/j.smim.2026.102055_bib51","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1038\/s41375-021-01158-9","article-title":"Danger-associated molecular pattern molecules take unexpectedly a central stage in Nlrp3 inflammasome-caspase-1-mediated trafficking of hematopoietic stem\/progenitor cells","volume":"35","author":"Thapa","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.smim.2026.102055_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3001746","article-title":"Tumor-derived interleukin-1\u03b1 and leukemia inhibitory factor promote extramedullary hematopoiesis","volume":"21","author":"Barisas","year":"2023","journal-title":"PLoS. Biol."},{"key":"10.1016\/j.smim.2026.102055_bib53","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1038\/s41556-023-01291-w","article-title":"Breast cancer remotely imposes a myeloid bias on haematopoietic stem cells by reprogramming the bone marrow niche","volume":"25","author":"Gerber-Ferder","year":"2023","journal-title":"Nat. Cell. Biol."},{"key":"10.1016\/j.smim.2026.102055_bib54","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1158\/0008-5472.CAN-06-3037","article-title":"The terminology issue for myeloid-derived suppressor cells","volume":"67","author":"Gabrilovich","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.smim.2026.102055_bib55","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12150","article-title":"Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards","volume":"7","author":"Bronte","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.smim.2026.102055_bib56","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.immuni.2021.04.004","article-title":"MDSC: markers, development, states, and unaddressed complexity","volume":"54","author":"Hegde","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.smim.2026.102055_bib57","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1189\/jlb.4RI0515-204R","article-title":"Transcriptional regulation of myeloid-derived suppressor cells","volume":"98","author":"Condamine","year":"2015","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.smim.2026.102055_bib58","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00262-008-0523-4","article-title":"Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy","volume":"58","author":"Diaz-Montero","year":"2009","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.smim.2026.102055_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10132872","article-title":"MDSC in mice and men: mechanisms of immunosuppression in cancer","volume":"10","author":"Vanhaver","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.smim.2026.102055_bib60","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41571-022-00620-6","article-title":"Clinical relevance of tumour-associated macrophages","volume":"19","author":"Pittet","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.smim.2026.102055_bib61","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41577-020-00490-y","article-title":"Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity","volume":"21","author":"Veglia","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.smim.2026.102055_bib62","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1084\/jem.20131916","article-title":"PD-L1 is a novel direct target of HIF-1\u03b1, and its blockade under hypoxia enhanced MDSC-mediated T cell activation","volume":"211","author":"Noman","year":"2014","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.smim.2026.102055_bib63","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/nm1609","article-title":"Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer","volume":"13","author":"Nagaraj","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.smim.2026.102055_bib64","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.4049\/jimmunol.1201449","article-title":"Myeloid-derived suppressor cells suppress antitumor immune responses through IDO expression and correlate with lymph node metastasis in patients with breast cancer","volume":"190","author":"Yu","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2026.102055_bib65","doi-asserted-by":"crossref","first-page":"5693","DOI":"10.4049\/jimmunol.0900092","article-title":"Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells","volume":"182","author":"Corzo","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2026.102055_bib66","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1158\/0008-5472.CAN-05-1299","article-title":"Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host","volume":"66","author":"Huang","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.smim.2026.102055_bib67","doi-asserted-by":"crossref","first-page":"5602","DOI":"10.4049\/jimmunol.1201018","article-title":"Tumor-infiltrating monocytic myeloid-derived suppressor cells mediate CCR5-dependent recruitment of regulatory T cells favoring tumor growth","volume":"189","author":"Schlecker","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2026.102055_bib68","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.3389\/fimmu.2020.01749","article-title":"The emerging role of neutrophil extracellular traps (NETs) in tumor progression and metastasis","volume":"11","author":"Masucci","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.smim.2026.102055_bib69","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1038\/s41586-025-09493-y","article-title":"Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours","volume":"646","author":"Hegde","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.smim.2026.102055_bib70","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1038\/s41591-018-0205-5","article-title":"Late-stage tumors induce anemia and immunosuppressive extramedullary erythroid progenitor cells","volume":"24","author":"Zhao","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.smim.2026.102055_bib71","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1182\/blood-2016-04-713206","article-title":"Mature CD10(+) and immature CD10(-) neutrophils present in G-CSF-treated donors display opposite effects on T cells","volume":"129","author":"Marini","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.smim.2026.102055_bib72","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1158\/0008-5472.CAN-14-3000","article-title":"Carbonic anhydrase IX promotes myeloid-derived suppressor cell mobilization and establishment of a metastatic niche by stimulating G-CSF production","volume":"75","author":"Chafe","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.smim.2026.102055_bib73","doi-asserted-by":"crossref","first-page":"6079","DOI":"10.1073\/pnas.1303302110","article-title":"Oncogenic RAS pathway activation promotes resistance to anti-VEGF therapy through G-CSF-induced neutrophil recruitment","volume":"110","author":"Phan","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.smim.2026.102055_bib74","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/bjc.1992.106","article-title":"IL-1 production as a regulator of G-CSF and IL-6 production in CSF-producing cell lines","volume":"65","author":"Suzuki","year":"1992","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.smim.2026.102055_bib75","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1002\/2211-5463.13445","article-title":"G-CSF\/GM-CSF-induced hematopoietic dysregulation in the progression of solid tumors","volume":"12","author":"He","year":"2022","journal-title":"FEBS Open. Bio"},{"key":"10.1016\/j.smim.2026.102055_bib76","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/eji.200939903","article-title":"Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF","volume":"40","author":"Dolcetti","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.smim.2026.102055_bib77","doi-asserted-by":"crossref","first-page":"6337","DOI":"10.1158\/0008-5472.CAN-04-0757","article-title":"High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells","volume":"64","author":"Serafini","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.smim.2026.102055_bib78","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.ccr.2012.04.025","article-title":"Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer","volume":"21","author":"Bayne","year":"2012","journal-title":"Cancer Cell."},{"key":"10.1016\/j.smim.2026.102055_bib79","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10549-009-0622-8","article-title":"GM-CSF is one of the main breast tumor-derived soluble factors involved in the differentiation of CD11b-Gr1- bone marrow progenitor cells into myeloid-derived suppressor cells","volume":"123","author":"Morales","year":"2010","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.smim.2026.102055_bib80","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.3389\/fonc.2019.01223","article-title":"IL-6 and IL-8 are linked with myeloid-derived suppressor cell accumulation and correlate with poor clinical outcomes in melanoma patients","volume":"9","author":"Tobin","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.smim.2026.102055_bib81","doi-asserted-by":"crossref","first-page":"3846","DOI":"10.1172\/JCI31871","article-title":"Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas","volume":"117","author":"Gao","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.smim.2026.102055_bib82","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002856","article-title":"IL-6 contributes to metastatic switch via the differentiation of monocytic-dendritic progenitors into prometastatic immune cells","volume":"9","author":"Magidey-Klein","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.smim.2026.102055_bib83","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2000915118","article-title":"Targeting tumor-derived NLRP3 reduces melanoma progression by limiting MDSCs expansion","volume":"118","author":"Tengesdal","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.smim.2026.102055_bib84","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.661323","article-title":"Tumor NLRP3-Derived IL-1\u03b2 drives the IL-6\/STAT3 axis resulting in sustained MDSC-mediated immunosuppression","volume":"12","author":"Tengesdal","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.smim.2026.102055_bib85","first-page":"553","article-title":"Serum levels of cytokines in patients with untreated primary lung cancer","volume":"2","author":"Katsumata","year":"1996","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.smim.2026.102055_bib86","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1043-4666(03)00185-6","article-title":"Cytokine profiles in patients receiving wide-field + prostate boost radiotherapy (xRT) for adenocarcinoma of the prostate","volume":"23","author":"Kovacs","year":"2003","journal-title":"Cytokine"},{"key":"10.1016\/j.smim.2026.102055_bib87","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/(SICI)1097-0215(19970529)71:5<724::AID-IJC6>3.0.CO;2-T","article-title":"Tumor-associated lympho-monocytes from neoplastic effusions are immunologically defective in comparison with patient autologous PBMCs but are capable of releasing high amounts of various cytokines","volume":"71","author":"Mantovani","year":"1997","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.smim.2026.102055_bib88","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1038\/bjc.2013.174","article-title":"Serum levels of IL-6 and IL-1\u03b2 can predict the efficacy of gemcitabine in patients with advanced pancreatic cancer","volume":"108","author":"Mitsunaga","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.smim.2026.102055_bib89","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0304-3835(95)03895-4","article-title":"Serum levels of interleukin-1, interleukin-6 and tumour necrosis factor-alpha in patients with gastric carcinoma","volume":"95","author":"Kabir","year":"1995","journal-title":"Cancer Lett."},{"key":"10.1016\/j.smim.2026.102055_bib90","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/j.ccell.2024.10.014","article-title":"Interleukin-1\u03b1 release during necrotic-like cell death generates myeloid-driven immunosuppression that restricts anti-tumor immunity","volume":"42","author":"H\u00e4nggi","year":"2024","journal-title":"Cancer Cell."},{"key":"10.1016\/j.smim.2026.102055_bib91","doi-asserted-by":"crossref","DOI":"10.1038\/srep14756","article-title":"IL-1\u03b1 is a DNA damage sensor linking genotoxic stress signaling to sterile inflammation and innate immunity","volume":"5","author":"Cohen","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.smim.2026.102055_bib92","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00586-18","article-title":"Uncoupling the senescence-associated secretory phenotype from cell cycle exit via interleukin-1 inactivation unveils its protumorigenic role","volume":"39","author":"Lau","year":"2019","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.smim.2026.102055_bib93","doi-asserted-by":"crossref","first-page":"549","DOI":"10.18632\/aging.101760","article-title":"S100A13 promotes senescence-associated secretory phenotype and cellular senescence via modulation of non-classical secretion of IL-1\u03b1","volume":"11","author":"Su","year":"2019","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.smim.2026.102055_bib94","doi-asserted-by":"crossref","first-page":"17031","DOI":"10.1073\/pnas.0905299106","article-title":"Cell surface-bound IL-1alpha is an upstream regulator of the senescence-associated IL-6\/IL-8 cytokine network","volume":"106","author":"Orjalo","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.smim.2026.102055_bib95","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.it.2025.03.001","article-title":"IL-1\u03b2(+) macrophages and the control of pathogenic inflammation in cancer","volume":"46","author":"Caronni","year":"2025","journal-title":"Trends Immunol."},{"key":"10.1016\/j.smim.2026.102055_bib96","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1038\/mi.2013.126","article-title":"Neutrophil infiltration favors colitis-associated tumorigenesis by activating the interleukin-1 (IL-1)\/IL-6 axis","volume":"7","author":"Wang","year":"2014","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.smim.2026.102055_bib97","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1158\/2326-6066.CIR-20-0431","article-title":"IL1\u03b2 promotes immune suppression in the tumor microenvironment independent of the inflammasome and gasdermin D","volume":"9","author":"Kiss","year":"2021","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.smim.2026.102055_bib98","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1158\/0008-5472.CAN-22-0651","article-title":"ATF3 reprograms the bone marrow niche in response to early breast cancer transformation","volume":"83","author":"Perrone","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.smim.2026.102055_bib99","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1189\/jlb.0905509","article-title":"Immune phenomena involved in the in vivo regression of fibrosarcoma cells expressing cell-associated IL-1alpha","volume":"80","author":"Dvorkin","year":"2006","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.smim.2026.102055_bib100","doi-asserted-by":"crossref","first-page":"8200","DOI":"10.4049\/jimmunol.175.12.8200","article-title":"CD11b+\/Gr-1+ immature myeloid cells mediate suppression of T cells in mice bearing tumors of IL-1beta-secreting cells","volume":"175","author":"Song","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2026.102055_bib101","doi-asserted-by":"crossref","first-page":"284","DOI":"10.4049\/jimmunol.176.1.284","article-title":"Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression","volume":"176","author":"Bunt","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2026.102055_bib102","doi-asserted-by":"crossref","first-page":"10019","DOI":"10.1158\/0008-5472.CAN-07-2354","article-title":"Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression","volume":"67","author":"Bunt","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.smim.2026.102055_bib103","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1158\/2326-6066.CIR-25-0651","article-title":"IL1R2 deficiency unleashes neutrophil-mediated antitumor potential in sarcoma","volume":"14","author":"Mariancini","year":"2026","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.smim.2026.102055_bib104","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nature14282","article-title":"IL-17-producing \u03b3\u03b4 T cells and neutrophils conspire to promote breast cancer metastasis","volume":"522","author":"Coffelt","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.smim.2026.102055_bib105","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1334744","article-title":"Mammary tumor-derived CCL2 enhances pro-metastatic systemic inflammation through upregulation of IL1\u03b2 in tumor-associated macrophages","volume":"6","author":"Kersten","year":"2017","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.smim.2026.102055_bib106","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/s41586-019-1450-6","article-title":"Loss of p53 triggers WNT-dependent systemic inflammation to drive breast cancer metastasis","volume":"572","author":"Wellenstein","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.smim.2026.102055_bib107","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.ccell.2025.04.007","article-title":"Understanding and reversing mammary tumor-driven reprogramming of myelopoiesis to reduce metastatic spread","volume":"43","author":"Garner","year":"2025","journal-title":"Cancer Cell."},{"key":"10.1016\/j.smim.2026.102055_bib108","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/ijc.34671","article-title":"Age at diagnosis for lung, colon, breast and prostate cancers: an international comparative study","volume":"154","author":"Zahed","year":"2024","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.smim.2026.102055_bib109","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41568-019-0222-9","article-title":"How the ageing microenvironment influences tumour progression","volume":"20","author":"Fane","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.smim.2026.102055_bib110","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.chom.2011.04.006","article-title":"Trained immunity: a memory for innate host defense","volume":"9","author":"Netea","year":"2011","journal-title":"Cell. Host Microbe"},{"key":"10.1016\/j.smim.2026.102055_bib111","doi-asserted-by":"crossref","first-page":"6062","DOI":"10.1038\/s41467-023-41691-y","article-title":"Perivascular niche cells sense thrombocytopenia and activate hematopoietic stem cells in an IL-1 dependent manner","volume":"14","author":"Luis","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.smim.2026.102055_bib112","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.immuni.2019.06.006","article-title":"Plasma cells are obligate effectors of enhanced myelopoiesis in aging bone marrow","volume":"51","author":"Pioli","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.smim.2026.102055_bib113","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.mad.2007.10.003","article-title":"Age-related increase of tumor susceptibility is associated with myeloid-derived suppressor cell mediated suppression of T cell cytotoxicity in recombinant inbred BXD12 mice","volume":"128","author":"Grizzle","year":"2007","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.smim.2026.102055_bib114","doi-asserted-by":"crossref","first-page":"697","DOI":"10.4049\/jimmunol.1002987","article-title":"A role for immature myeloid cells in immune senescence","volume":"186","author":"Enioutina","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2026.102055_bib115","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.3389\/fimmu.2018.01122","article-title":"Parameters of the immune system and vitamin D levels in old individuals","volume":"9","author":"Alves","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.smim.2026.102055_bib116","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/acel.12571","article-title":"Expansion of myeloid-derived suppressor cells with aging in the bone marrow of mice through a NF-\u03baB-dependent mechanism","volume":"16","author":"Flores","year":"2017","journal-title":"Aging Cell."},{"key":"10.1016\/j.smim.2026.102055_bib117","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/aac2.70006","article-title":"Age-related changes in myeloid cells and their impact on subcutaneous melanoma growth in mice","volume":"6","author":"Landreth","year":"2025","journal-title":"Aging Cancer"},{"key":"10.1016\/j.smim.2026.102055_bib118","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1189\/jlb.0912461","article-title":"Blood CD33(+)HLA-DR(-) myeloid-derived suppressor cells are increased with age and a history of cancer","volume":"93","author":"Verschoor","year":"2013","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.smim.2026.102055_bib119","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.exger.2014.12.001","article-title":"Myeloid-derived suppressor cells promote age-related increase of lung cancer growth via B7-H1","volume":"61","author":"Chen","year":"2015","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.smim.2026.102055_bib120","doi-asserted-by":"crossref","DOI":"10.1126\/science.adn0327","article-title":"Hematopoietic aging promotes cancer by fueling IL-1\u237a-driven emergency myelopoiesis","volume":"386","author":"Park","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.smim.2026.102055_bib121","article-title":"Inflammatory reprogramming of the solid tumor microenvironment by infiltrating clonal hematopoiesis is associated with adverse outcomes","volume":"6","author":"Buttigieg","year":"2025","journal-title":"Cell. Rep. Med."},{"key":"10.1016\/j.smim.2026.102055_bib122","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/S1470-2045(14)70155-X","article-title":"MABp1, a first-in-class true human antibody targeting interleukin-1\u03b1 in refractory cancers: an open-label, phase 1 dose-escalation and expansion study","volume":"15","author":"Hong","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.smim.2026.102055_bib123","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s10637-015-0226-6","article-title":"Xilonix, a novel true human antibody targeting the inflammatory cytokine interleukin-1 alpha, in non-small cell lung cancer","volume":"33","author":"Hong","year":"2015","journal-title":"Invest. New. Drugs"},{"key":"10.1016\/j.smim.2026.102055_bib124","doi-asserted-by":"crossref","first-page":"5243","DOI":"10.1158\/0008-5472.CAN-18-0413","article-title":"IL1 receptor antagonist controls transcriptional signature of inflammation in patients with metastatic breast cancer","volume":"78","author":"Wu","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.smim.2026.102055_bib125","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1474319","article-title":"Fluorouracil and bevacizumab plus anakinra for patients with metastatic colorectal cancer refractory to standard therapies (IRAFU): a single-arm phase 2 study","volume":"7","author":"Isambert","year":"2018","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.smim.2026.102055_bib126","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/S0140-6736(17)32247-X","article-title":"Effect of interleukin-1\u03b2 inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial","volume":"390","author":"Ridker","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.smim.2026.102055_bib127","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1200\/JCO.23.00910","article-title":"Canakinumab as adjuvant therapy in patients with completely resected non-small-cell lung cancer: results from the CANOPY-A double-blind, randomized clinical trial","volume":"42","author":"Garon","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.smim.2026.102055_bib128","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1200\/JCO.23.00980","article-title":"Canakinumab versus placebo in combination with first-line pembrolizumab plus chemotherapy for advanced non\u2013small-cell lung cancer: results from the CANOPY-1 trial","volume":"42","author":"Tan","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.smim.2026.102055_bib129","unstructured":"Pandya, T., Zagorulya, M., Leung, M.M., Augustine, M., Liu, L.Y., Lepp\u00e4, A.-M., Baruchel, U., Ng, S.W., Klockner, T., Mugabo, M., et al. Plasma signals of lung tumor promotion for molecular cancer prevention. Cell. 10.1016\/j.cell.2026.05.005."},{"key":"10.1016\/j.smim.2026.102055_bib130","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic\/Dendritic Neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.smim.2026.102055_bib131","article-title":"Clonal hematopoiesis: impact on health and disease","volume":"43","author":"Caiado","year":"2025","journal-title":"Hematol. Oncol."},{"key":"10.1016\/j.smim.2026.102055_bib132","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/s41577-023-00843-3","article-title":"Clonal haematopoiesis and dysregulation of the immune system","volume":"23","author":"Belizaire","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.smim.2026.102055_bib133","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.exphem.2017.08.001","article-title":"Tet2 restrains inflammatory gene expression in macrophages","volume":"55","author":"Cull","year":"2017","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.smim.2026.102055_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.exphem.2026.105383","article-title":"TET2 loss enhances early response to inflammation in primitive and committed myeloid cells","volume":"157","author":"Jenkins","year":"2026","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.smim.2026.102055_bib135","doi-asserted-by":"crossref","DOI":"10.1172\/JCI171002","article-title":"Neutrophil-mediated innate immune resistance to bacterial pneumonia is dependent on Tet2 function","volume":"134","author":"Quin","year":"2024","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.smim.2026.102055_bib136","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.031665","article-title":"Association between clonal hematopoiesis driver mutations, immune cell function, and the vasculometabolic complications of obesity","volume":"13","author":"Tercan","year":"2024","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.smim.2026.102055_bib137","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.exphem.2017.11.002","article-title":"An inflammatory environment containing TNF\u03b1 favors Tet2-mutant clonal hematopoiesis","volume":"59","author":"Abegunde","year":"2018","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.smim.2026.102055_bib138","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.stem.2018.10.013","article-title":"Inhibition of inflammatory signaling in Tet2 mutant preleukemic cells mitigates stress-induced abnormalities and clonal hematopoiesis","volume":"23","author":"Cai","year":"2018","journal-title":"Cell. Stem Cell."},{"key":"10.1016\/j.smim.2026.102055_bib139","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1182\/blood.2022016835","article-title":"Aging drives Tet2+\/- clonal hematopoiesis via IL-1 signaling","volume":"141","author":"Caiado","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.smim.2026.102055_bib140","doi-asserted-by":"crossref","first-page":"8102","DOI":"10.1038\/s41467-023-43697-y","article-title":"Clonal hematopoiesis related TET2 loss-of-function impedes IL1\u03b2-mediated epigenetic reprogramming in hematopoietic stem and progenitor cells","volume":"14","author":"McClatchy","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.smim.2026.102055_bib141","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/s41586-018-0125-z","article-title":"Microbial signals drive pre-leukaemic myeloproliferation in a Tet2-deficient host","volume":"557","author":"Meisel","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.smim.2026.102055_bib142","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1158\/2643-3230.BCD-25-0070","article-title":"Human TET2-mutant clonal hematopoiesis expansion is driven by distinct inflammatory signaling responses in stem cells versus myeloid progeny","volume":"7","author":"Huerga Encabo","year":"2026","journal-title":"Blood Cancer Discov."},{"key":"10.1016\/j.smim.2026.102055_bib143","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1126\/science.aag1381","article-title":"Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice","volume":"355","author":"Fuster","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.smim.2026.102055_bib144","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1161\/CIRCRESAHA.118.313225","article-title":"CRISPR-mediated gene editing to assess the roles of Tet2 and Dnmt3a in clonal hematopoiesis and cardiovascular disease","volume":"123","author":"Sano","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.smim.2026.102055_bib145","first-page":"805","article-title":"Loss-of-function mutations in Dnmt3a and Tet2 lead to accelerated atherosclerosis and concordant macrophage phenotypes","volume":"2","author":"Rauch","year":"2023","journal-title":"Nat. Cardiovasc. Res."},{"key":"10.1016\/j.smim.2026.102055_bib146","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/s41586-023-05857-4","article-title":"Clonal haematopoiesis and risk of chronic liver disease","volume":"616","author":"Wong","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.smim.2026.102055_bib147","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/s41586-020-2819-2","article-title":"Inherited causes of clonal haematopoiesis in 97,691 whole genomes","volume":"586","author":"Bick","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.smim.2026.102055_bib148","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1001\/jamacardio.2022.0386","article-title":"TET2-driven clonal hematopoiesis and response to canakinumab: an exploratory analysis of the CANTOS randomized clinical trial","volume":"7","author":"Svensson","year":"2022","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.smim.2026.102055_bib149","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1038\/s41375-022-01665-3","article-title":"Il-1r1 drives leukemogenesis induced by Tet2 loss","volume":"36","author":"Burns","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.smim.2026.102055_bib150","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.stem.2024.05.010","article-title":"Selective advantage of mutant stem cells in human clonal hematopoiesis is associated with attenuated response to inflammation and aging","volume":"31","author":"Jakobsen","year":"2024","journal-title":"Cell. Stem Cell."},{"key":"10.1016\/j.smim.2026.102055_bib151","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.stem.2017.07.010","article-title":"Therapy-related clonal hematopoiesis in patients with non-hematologic cancers is common and associated with adverse clinical outcomes","volume":"21","author":"Coombs","year":"2017","journal-title":"Cell. Stem Cell."},{"key":"10.1016\/j.smim.2026.102055_bib152","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/s41588-022-01121-z","article-title":"Genome-wide analyses of 200,453 individuals yield new insights into the causes and consequences of clonal hematopoiesis","volume":"54","author":"Kar","year":"2022","journal-title":"Nat. Genet."},{"key":"10.1016\/j.smim.2026.102055_bib153","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s41586-022-05448-9","article-title":"Common and rare variant associations with clonal haematopoiesis phenotypes","volume":"612","author":"Kessler","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.smim.2026.102055_bib154","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1200\/JCO.22.00857","article-title":"Clonal hematopoiesis and risk of incident lung cancer","volume":"41","author":"Tian","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.smim.2026.102055_bib155","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1182\/blood.2021014108","article-title":"Clonal hematopoiesis is associated with improved survival in patients with metastatic colorectal cancer from the FIRE-3 trial","volume":"139","author":"Arends","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.smim.2026.102055_bib156","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1056\/NEJMoa2413361","article-title":"Tumor-infiltrating clonal hematopoiesis","volume":"392","author":"Pich","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.smim.2026.102055_bib157","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12979-025-00524-w","article-title":"Aging modulates the immunosuppressive, polarizing and metabolic functions of blood-derived myeloid-derived suppressor cells (MDSCs)","volume":"22","author":"Keltsch","year":"2025","journal-title":"Immun. Ageing"},{"key":"10.1016\/j.smim.2026.102055_bib158","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1158\/0008-5472.CAN-24-3329","article-title":"Response to immune checkpoint blockade is enhanced in the presence of hematopoietic TET2 inactivation","volume":"86","author":"Rondeau","year":"2026","journal-title":"Cancer Res."},{"key":"10.1016\/j.smim.2026.102055_bib159","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ccell.2025.09.011","article-title":"TET2-mutant clonal hematopoiesis enhances macrophage antigen presentation and improves immune checkpoint therapy in solid tumors","volume":"44","author":"Herbrich","year":"2026","journal-title":"Cancer Cell."}],"container-title":["Seminars in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044532326000424?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044532326000424?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T20:40:55Z","timestamp":1788900055000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044532326000424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":159,"alternative-id":["S1044532326000424"],"URL":"https:\/\/doi.org\/10.1016\/j.smim.2026.102055","relation":{},"ISSN":["1044-5323"],"issn-type":[{"value":"1044-5323","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IL-1-mediated cancer-adapted hematopoiesis in aging and clonal hematopoiesis","name":"articletitle","label":"Article Title"},{"value":"Seminars in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.smim.2026.102055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102055"}}